Case 33-2008: A 63-year-old woman with dyspnea on exertion

New England Journal of Medicine

Volumn 359, Issue 17, 2008, Pages 1823-1832

  Wiener, Charles M ^a,b   Muse, Victorine V ^c,d   Mark, Eugene J ^c,d  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; AZITHROMYCIN; BALSALAZIDE; CEFTRIAXONE; HYDROCORTISONE; IBUPROFEN; INFLIXIMAB; LEVOFLOXACIN; ONDANSETRON; PARACETAMOL; PREDNISONE; IMMUNOSUPPRESSIVE AGENT; MONOCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANAMNESIS; ARTICLE; BRONCHOSCOPY; CASE REPORT; CELL COUNT; CLINICAL EXAMINATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DRUG WITHDRAWAL; DYSPNEA; ELECTROCARDIOGRAPHY; EXERCISE; FEMALE; HUMAN; LABORATORY TEST; LUNG DISEASE; LUNG LAVAGE; MASSAGE; NAUSEA; PAIN; PRIORITY JOURNAL; THORAX RADIOGRAPHY; ULCERATIVE COLITIS; CHEMICALLY INDUCED DISORDER; CLINICAL OBSERVATION; CLINICAL STUDY; DIAGNOSIS; DIFFERENTIAL DIAGNOSIS; DRUG ANTAGONISM; DRUG HYPERSENSITIVITY; EOSINOPHILIA; IMMUNOLOGY; INTERSTITIAL LUNG DISEASE; LUNG; MIDDLE AGED; PATHOLOGY; PNEUMONIA; RADIOGRAPHY;

ANTIBODIES, MONOCLONAL; COLITIS, ULCERATIVE; DIAGNOSIS, DIFFERENTIAL; DRUG HYPERSENSITIVITY; DYSPNEA; EOSINOPHILIA; EXERTION; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUNG; LUNG DISEASES, INTERSTITIAL; MIDDLE AGED; PNEUMONIA; TOMOGRAPHY, X-RAY COMPUTED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 54949105406     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMcpc0806979     Document Type: Article

References (16)

1. Collins J. CT signs and patterns of lung disease. Radiol Clin North Am 2001;39:1115-35.
2. Miller WT Jr, Shah RM. Isolated diffuse ground-glass opacity in thoracic CT: causes and clinical presentations. AJR Am J Roentgenol 2005;184:613-22.
3. Costabel U, Uzaslan E, Guzman J. Bronchoalveolar lavage in drug-induced lung disease. Clin Chest Med 2004;25:25-35.
4. Meyer KC. The role of bronchoalveolar lavage in interstitial lung disease. Clin Chest Med 2004;25:637-49.
5. Childs B, Wiener C, Valle D. A science of the individual: implications for a medical school curriculum. Annu Rev Genomics Hum Genet 2005;6:313-30.
6. Lawson MM, Thomas AG, Akobeng AK. Tumour necrosis factor alpha blocking agents for induction of remission in ulcerative colitis. Cochrane Database Syst Rev 2006;3:CD005112.
7. Wallis RS, Broder MS, Wong JY, Hanson ME, Beenhouwer DO. Granulomatous infectious diseases associated with tumor necrosis factor antagonists. Clin Infect Dis 2004;38:1261-5.
8. Saketkoo LA, Espinoza LR. Impact of biologic agents on infectious diseases. Infect Dis Clin North Am 2006;20:931-61.
9. Mennink-Kersten MA, Verweij PE. Non-culture-based diagnostics for opportunistic fungi. Infect Dis Clin North Am 2006;20:711-27.
10. Storch I, Sachar D, Katz S. Pulmonary manifestations of inflammatory bowel disease. Inflamm Bowel Dis 2003;9:104-15.
11. Müller NL, White DA, Jiang H, Gemma A. Diagnosis and management of drug-associated interstitial lung disease. Br J Cancer 2004;91:Suppl 2:S24-S30.
12. Allen JN. Drug-induced eosinophilic lung disease. Clin Chest Med 2004;25:77-88.
13. Epler GR. Drug-induced bronchiolitis obliterans organizing pneumonia. Clin Chest Med 2004;25:89-94.
14. Muijsers RB, Goa KL. Balsalazide: a review of its therapeutic use in mild-to-moderate ulcerative colitis. Drugs 2002;62:1689-705.
15. Parry SD, Barbatzas C, Peel ET, Barton JR. Sulphasalazine and lung toxicity. Eur Respir J 2002;19:756-64.
16. Villeneuve E, St-Pierre A, Haraoui B. Interstitial pneumonitis associated with infliximab therapy. J Rheumatol 2006;33:1189-93.